Seeing Is Believing
Currently out of the existing stock ratings of Srikripa Devarakonda, 24 are a BUY (100%).
Analyst Srikripa Devarakonda works at TRUIST with a stock forecast success ratio of 14.29% fulfilled within 43.14 days on average.
Srikripa Devarakonda’s has documented 51 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INCY, yte at 01-May-2024.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/3/2023. The price target of $41 was fulfilled within 112 days with a profit of $26.73 (187.32%) receiving and performance score of 16.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
80
$26.24 (48.81%)
93
3 days ago
0/3 (0%)
$27.06 (51.11%)
Hold
52
$-1.76 (-3.27%)
64
3 days ago
9/13 (69.23%)
$-0.94 (-1.78%)
57
Buy
83
$29.24 (54.39%)
84
3 days ago
0/8 (0%)
$30.06 (56.78%)
Buy
84
$30.24 (56.25%)
92
10 days ago
6/14 (42.86%)
$32.26 (62.35%)
62
Hold
65
$11.24 (20.91%)
65
1 months 9 days ago
18/33 (54.55%)
$7.52 (13.08%)
193
Which stock is Srikripa Devarakonda is most bullish on?
Which stock is Srikripa Devarakonda is most reserved on?
What Year was the first public recommendation made by Srikripa Devarakonda?